EXSCIEN CORPORATION
Biotech · Defunct
Exscien III, an engineered fusion protein that traffics glycosylase to mitochondria to enhance mtDNA repair in heart failure
exsciencorp.com →- Grants
- $5.3M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Mitochondrial DNA repair agents for acute lung injury | $3,196,272 | |
| Federal grant | Department of Health and Human Services · Phase I · Mitochondrial TAT-DNA repair proteins for treatment of insulin resistance | $296,128 | |
| Federal grant | Department of Health and Human Services · Phase II · Mitochondrial DNA repair agents for acute lung injury | $1,538,412 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Mitochondrial DNA Repair Enzyme for Heart Failure | $296,503 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1472 | Aptorum Group Ltd | — | $1.6M |
| 1473 | RESBIOTIC, INC. | — | $1.6M |
| 1474 | UBIVAC, INC. | — | $1.5M |
| 1475 | EXSCIEN CORPORATION | — | — |
| 1476 | SirnaMed Therapeutics Inc. | — | $1.3M |
| 1477 | AstralBio, Inc. | — | $957K |
| 1478 | ACHERX LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.